Healthcare provider profile · identity verified

Aaron M. Heiar, DO

Family Practice · IOWA FALLS, IA · NPI 1558321075

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	494	126
Levothyroxine Sodium	Levothyroxine Sodium	434	83
Amlodipine Besylate	Amlodipine Besylate	315	79
Lisinopril	Lisinopril	272	78
Omeprazole	Omeprazole	250	63
Furosemide	Furosemide	231	49
Simvastatin	Simvastatin	221	55
Metoprolol Succinate	Metoprolol Succinate	200	45
Losartan Potassium	Losartan Potassium	191	47
Hydrochlorothiazide	Hydrochlorothiazide	159	44
Sertraline Hcl	Sertraline Hcl	145	31
Alendronate Sodium	Alendronate Sodium	126	21
Eliquis	Apixaban	125	19
Potassium Chloride	Potassium Chloride	117	22
Metformin Hcl	Metformin Hcl	114	32
Gabapentin	Gabapentin	113	25
Tamsulosin Hcl	Tamsulosin Hcl	112	28
Ozempic	Semaglutide	110	19
Glipizide	Glipizide	108	25
Famotidine	Famotidine	106	19
Tramadol Hcl	Tramadol Hcl	103	20
Trazodone Hcl	Trazodone Hcl	101	19
Montelukast Sodium	Montelukast Sodium	89	21
Metoprolol Tartrate	Metoprolol Tartrate	87	21
Allopurinol	Allopurinol	85	16
Escitalopram Oxalate	Escitalopram Oxalate	84	18
Rosuvastatin Calcium	Rosuvastatin Calcium	84	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	21
Prednisone	Prednisone	78	50
Pravastatin Sodium	Pravastatin Sodium	73	17
Metformin Hcl Er	Metformin Hcl	69	17
Fentanyl	Fentanyl	67	suppressed
Xarelto	Rivaroxaban	64	suppressed
Memantine Hcl	Memantine Hcl	63	16
Spironolactone	Spironolactone	57	suppressed
Jardiance	Empagliflozin	56	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	54	15
Warfarin Sodium	Warfarin Sodium	53	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	13
Clopidogrel	Clopidogrel Bisulfate	46	14
Azithromycin	Azithromycin	45	37
Fluticasone Propionate	Fluticasone Propionate	45	suppressed
Bumetanide	Bumetanide	43	suppressed
Donepezil Hcl	Donepezil Hcl	43	suppressed
Xifaxan	Rifaximin	40	suppressed
Carvedilol	Carvedilol	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Lorazepam	Lorazepam	37	suppressed
Alprazolam	Alprazolam	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	26
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Atenolol	Atenolol	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Cephalexin	Cephalexin	30	21
Clonazepam	Clonazepam	30	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Colestipol Hcl	Colestipol Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Finasteride	Finasteride	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	15
Pregabalin	Pregabalin	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Meloxicam	Meloxicam	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	14
Baclofen	Baclofen	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Metolazone	Metolazone	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Tacrolimus	Tacrolimus	13	suppressed
Topiramate	Topiramate	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Mycophenolic Acid	Mycophenolate Sodium	12	suppressed
Risperidone	Risperidone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Levetiracetam Er	Levetiracetam	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error